Drug Topics January/February 2025

More detailed information can be found on the CDC’s website at www.cdc.gov/vaccines.

Tryvio was given FDA approval on March 19, 2024.

Help your patients overcome tummy troubles with trusted OTC products that relieve bloating, heartburn, and more, promoting smooth and happy digestion.

Sarah Gray, PharmD, GAICD, explored the unique combination of being both a pharmacist and nutritionist.

Patients who receive either Pfizer or GSK’s respiratory syncytial virus vaccine may be at increased risk of Guillain-Barré syndrome.

US News & World Report nutrition experts detailed the best types of diets for maintaining patient health in 2025.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the benefits of glucagon and why pharmacists should be able to prescribe it.

Two posters presented at the meeting looked into the topic CGMs in diabetes care.

Drug Topics met with Amanuel Kehasse, PharmD, PhD, to discuss the barriers surrounding biosimilar implementation in the prescription drug market.

Kathryn Litten, PharmD, discussed the pharmacist’s role in helping patients manage metabolic dysfunction-associated steatotic liver disease.

John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.

Pharmacists can influence institutional-level climate change-related policies to ensure continued health care delivery.

A tour of modern antiretroviral and pre-exposure prophylaxis therapies included the latest updates in HIV management and prevention.

Patients with ASCVD experienced a more significant reduction in LDL-C.

Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.